{
    "organizations": [],
    "uuid": "d0455b08166ae0a70cd6760b18342d9d7a8e21d3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-lipocine-receives-complete-respons/brief-lipocine-receives-complete-response-letter-for-tlando-from-u-s-fda-idUSASC0A0W2",
    "ord_in_thread": 0,
    "title": "BRIEF-Lipocine Receives Complete Response Letter For Tlando From U.S. FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Lipocine Inc:\n* LIPOCINE RECEIVES COMPLETE RESPONSE LETTER FOR TLANDO FROM U.S. FOOD AND DRUG ADMINISTRATION\n* LIPOCINE - NEXT STEP TO REQUEST MEETING WITH FDA TO FURTHER EVALUATE DEFICIENCIES RAISED, TO AGREE ON PATH FORWARD FOR POTENTIAL APPROVAL OF TLANDO\n* LIPOCINE INC - CRL ALSO IDENTIFIED ADDITIONAL COMMENTS THAT ARE NOT CONSIDERED APPROVABILITY ISSUES\n* LIPOCINE INC - CRL IDENTIFIED FOUR DEFICIENCIES REGARDING ITS NEW DRUG APPLICATION FOR TLANDO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T19:01:00.000+03:00",
    "crawled": "2018-05-10T17:34:46.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "lipocine",
        "inc",
        "lipocine",
        "receives",
        "complete",
        "response",
        "letter",
        "tlando",
        "food",
        "drug",
        "administration",
        "lipocine",
        "next",
        "step",
        "request",
        "meeting",
        "fda",
        "evaluate",
        "deficiency",
        "raised",
        "agree",
        "path",
        "forward",
        "potential",
        "approval",
        "tlando",
        "lipocine",
        "inc",
        "crl",
        "also",
        "identified",
        "additional",
        "comment",
        "considered",
        "approvability",
        "issue",
        "lipocine",
        "inc",
        "crl",
        "identified",
        "four",
        "deficiency",
        "regarding",
        "new",
        "drug",
        "application",
        "tlando",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}